临床试验/NCT05912660

NCT05912660已完成不适用

Health Status of Patients After Surgically Implanted Biological and TAVI: a Population-based Retrospective Analysis

Medical University of Vienna0 个研究点目标入组 18,882 人开始时间: 2010年1月1日最近更新: 2023年6月22日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Medical University of Vienna
入组人数: 18,882
主要终点: all-cause mortality

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

The overall project aim is to study outcomes following aortic valve replacement with surgically implanted bioprostheses or TAVI by retrieving data from the main social security carriers in Austria for the years 2010-2020.

研究设计

研究类型: Observational
观察模型: Other
时间视角: Retrospective

入排标准

年龄范围: 65 Years 至 99 Years（Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•isolated aortic valve replacement in Austria (surgically implanted bioprostheses or TAVI)

排除标准

•below 65 years of age
•coronary revascularization within 4 months before the index procedure
•concomitant heart surgery

结局指标

主要结局

all-cause mortality

时间窗: 10 years

all cause mortality after aortic valve replacement

次要结局

stroke(10 years)
heart failure(10 years)
myocardial infaction(10 years)
reoperation(10 years)

研究者

发起方

Medical University of Vienna

申办方类型

Other

责任方

Principal Investigator

主要研究者

Hendrik Jan Ankersmit

Univ. Prof. , MD, MBA

Medical University of Vienna

相似试验

已完成

不适用

Health Status of Patients After Surgically Implanted Biological and Mechanical Aortic Valves: a Population-based Retrospective Analysis (2010-2018)Aortic Valve Disease

NCT04900909Medical University of Vienna13,993

已完成

不适用

Health Status of < 50 Year Old Patients After Surgically Implanted Biological and Mechanical Aortic Valves: a Population-based Retrospective Analysis (2010-2020)Aortic Valve Disease

NCT05627973Medical University of Vienna991

招募中

不适用

Functional and Quality of Life Improvement Following Transcatheter Heart Valve ImplantationTrans Catheter Aortic ValveAortic Stenosis

NCT02023060Sheba Medical Center100

进行中（未招募）

不适用

ASAN Medical Center Aortic Valve Replacement RegistryAortic Valve Stenosis

NCT03298178Ho-Jin Kim900

进行中（未招募）

不适用

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).Severe Aortic Stenosis

NCT01586910Medtronic Cardiovascular1,746